Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment

Clinical trial NCT05661461 · RECRUITING

Trial details

NCT number: NCT05661461
Sponsor: Aadi Bioscience, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Tumor, Solid Tumor Advanced Solid Tumor

Start date: 2022-11-23
Primary completion: 2026-06-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.